STAT+：心脏协会会议的数据读出结果呈“中性”趋势
摘要
芝加哥——如果用一个词来形容今年美国心脏协会科学年会上公布的研究，那可能是“中性”。会议以两项重磅研究的失望结果开场，这些结果在数周或数月前发布的顶线结果中已有所暗示，但在周六上午以毫不掩饰的具体细节进行了详尽披露。针对炎症的ZEUS试验显示，治疗组与安慰剂组之间没有差异。针对脂蛋白(a)的HORIZON试验也揭示了几乎相同的结果，无论参与者是否服药。换言之，中性。继续阅读STAT+以了解完整报道……
English
CHICAGO — If one word could describe research presented at this year’s American Heart Association scientific sessions, it might be “neutral.” The meeting began with two blockbuster disappointments, hinted at in top-line results released weeks or months ago but detailed with unvarnished specificity Saturday morning. The ZEUS trial targeting inflammation showed no difference between the treatment and placebo arms. The HORIZON trial taking aim at lipoprotein(a) also revealed nearly identical results, whether participants were on or off the drug. In other words, neutral. Continue to STAT+ to read the full story…